Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
VTE Incidence after Cesarean Delivery in Selected Guidelines

VTE Incidence after Cesarean Delivery in Selected Guidelines

T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

T1DM Mini-Series: Severe hypoglycaemia compromises the achievement of glycaemic control

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Hear from an expert on what are the main challenges in treating Patients with CRS with Nasal Polyps?

Do historical HbA1c values explain glycemic legacy effect of type 2 diabetes?

Do historical HbA1c values explain glycemic legacy effect of type 2 diabetes?

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

T1DM Mini-Series: Clinical implications of having hyperglycaemia with ketosis

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

ATTD 2021: Technology Supporting Initiation, Titration, and Intensification

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Hear from an expert on how can you limit the effects of systemic steroid use for Patients with CRS with Nasal Polyps?

Diabetes Your Type: Testimonial by Dr. Bassam​

Diabetes Your Type: Testimonial by Dr. Bassam​

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Rethink your Nasal Polyps. Type 2 Inflammation a Nasal Polyps mystery

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

T1DM Mini-Series: Edition Junior trial results

T1DM Mini-Series: Edition Junior trial results

Maternal and Perinatal Outcomes of VTE

Maternal and Perinatal Outcomes of VTE